Inactive Instrument

Hadasit Bio Holding Ltd. Stock price TEL AVIV STOCK EXCHANGE

Equities

IL0010954050

Biotechnology & Medical Research

Financials

Sales 2022 - Sales 2023 87K 23.73K 8.7M Capitalization 7.43M 2.03M 743M
Net income 2022 -31M -8.46M -3.1B Net income 2023 -29M -7.91M -2.9B EV / Sales 2022 -
Net cash position 2022 12.93M 3.53M 1.29B Net cash position 2023 6.46M 1.76M 646M EV / Sales 2023 11.1 x
P/E ratio 2022
-0.46 x
P/E ratio 2023
-0.25 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 25%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 63 15-09-19
Chairman 60 14-05-17
Comptroller/Controller/Auditor 53 15-08-30
Members of the board TitleAgeSince
Director/Board Member 68 18-07-28
Director/Board Member 66 16-07-04
Director/Board Member 53 17-10-31
More insiders
HBL Hadasit Bio Holdings Ltd (Hadasit) is an investment company, a subsidiary of Hadassah Medical Organization (HMO). The Company's subsidiaries enable research and development and promote intellectual property (IP) to the medical and biotechnological industries. The Company together with its strategic partners, has established a number of start-up companies, and is assigned to commercialize that IP either through granting a product license to biotechnological or pharmaceutical companies or via the creation of a subsidiary which operates in the premise of HMO. Hadasit is equipped with resources and capabilities required for composing and conducting the pre-clinical services and clinical studies, establishing start-up companies, offering product licensing and providing international consulting services. The Company's framework serves to address investment in early-stage biotechnological star-ups, by distributing both risk and success amongst a number of companies.
More about the company
  1. Stock
  2. Equities
  3. Stock HBL - Hadasit Bio-Holdings Ltd
  4. Stock Hadasit Bio Holding Ltd. - TEL AVIV STOCK EXCHANGE